SWOT Analysis
- S
- W
- O
- T
Technical Analysis
Moving Averages
We appreciate your patience. Your content is on the way.
Current Price


- Bullish Moving Averages
- Bearish Moving Averages
Resistance and support
We appreciate your patience. Your content is on the way.
Company Financials
- Profit and loss statement
- Balance sheet
- Quarterly Result
- Ratio
We appreciate your patience. Your content is on the way.
Quick Results Snapshot
We appreciate your patience. Your content is on the way.
Stocks Comparison
Table
Chart
We appreciate your patience. Your content is on the way.
Corporate Action
- Announcement
- Board Meeting
- Dividend
- Split
- Rights
- Events
Insider & Institutional Activity
- Bulk Block Deals
- Insider Trading & SAST
We appreciate your patience. Your content is on the way.
About J K Pharmachem Ltd
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Jointly promoted by J K Industries and TIDCO, J K Pharmachem manufactures drugs and pharmaceuticals. It entered the capital market in Oct.`94 to part-finance the setting up of a plant to manufacture 1250 MMU P.a of pencillin-G, based on a microbial strain from the technical collaborators -- IGC (Cyprus), Cyprus -- a wholly-owned subsidiary of ICN Galenika. Commercial production at this plant commenced in Oct.`95. The company has a tie-up with ICN Galenika, part of the ICN Pharmaceuticals group (one of the pioneering manufacturers of pencillin-G), to set up a 1250-mmu capacity plant. It has already produced international standard penicillin with Indian raw materials, at its collaborator`s plant which is among the best in the world. In addition, J K Pharmachem had set-up its own R&D activity well in advance for future development in the field of bio-technology. A pilot plant is also being established for this purpose at Cuddalore, Tamilnadu. The company also plans to diversify into speciality fermentation products. It has also started production of Penicillin-V and is the only one in India to produce this bulk active. During 1999-2000, the company started the production of Penicillin V and is the only producer of this important bulk active in India. The accumulated losses of the company having exceeded 50% of the peak networth of the company in the immediately preceding four financial years, the company took the necessary steps of SICA, 1985. The company developed an in-house and launched viz JKZyme, an environment new product of paper & pulp. Commercial trails are under way in India and abroad. The company has produced 1192 MMU of Penicillin-G during the financial year 2003-04 and retained its status as the second largest producer with a market share of 24%.
J K Pharmachem share price as on 13 Jul 2025 is Rs. . Over the past 6 months, the J K Pharmachem share price has increased by 0% and in the last one year, it has increased by 0%. The 52-week low for J K Pharmachem share price was Rs. and 52-week high was Rs. .
500218
JKPHARMA
INE335C01018
Jan
J K Pharmachem Ltd FAQs
You can buy J K Pharmachem Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy J K Pharmachem Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of the closing price of J K Pharmachem Ltd was Rs.-.
The latest PE ratio of J K Pharmachem Ltd as of is 0.00
The latest PB ratio of J K Pharmachem Ltd as of is 0.00
The 52-week high of J K Pharmachem Ltd share price is Rs. 0.00 while the 52-week low is Rs. 0.00
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of , the market cap of J K Pharmachem Ltd stood at Rs. 0.00 Cr.
Market Outlook
View allWe appreciate your patience. Your content is on the way.